With AI taking more and more space in biotech, CRISPR stands out as one of the most promising avenues for AI integration.

The identification of genes involved in diseases is one of the major challenges of biomedical research. Researchers at the ...

Within the human digestive tract are trillions of bacteria from thousands of different species. These bacteria form ...

In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against the other gene therapy stocks. Gene therapy is referred to as a medical technique that ...

There's no way to treat it. In principle, CRISPR, the gene-editing technique that enables scientists to easily make very ...

Researchers have uncovered a serious side effect of using the CRISPR-Cas gene scissors. A molecule designed to make the process more efficient destroys parts of the genome. Genome editing with ...

CRISPR Therapeutics AG (CRSP) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

Thanks to CRISPR, medical specialists will soon have unprecedented control over how they treat and prevent some of the most challenging genetic disorders and diseases. CRISPR (Clustered Regularly ...